5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis

5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis

BackgroundSeveral studies have confirmed the impact of 5-aminolevulinic acid (5-ALA) on the extent of resection in newly diagnosed glioblastoma (GBM). However, there are controversies on the 5-ALA fluorescence status in recurrent GBM surgery, with specific reference to pseudoprogression or radionecr...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Luca Ricciardi, Carmelo Lucio Sturiale, Alba Scerrati, Vito Stifano, Teresa Somma, Tamara Ius, Sokol Trungu, Michele Acqui, Antonino Raco, Massimo Miscusi, Giuseppe Maria Della Pepa
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Frontiers Media S.A. 2022-02-01
Σειρά:	Frontiers in Oncology
Θέματα:	glioblastoma high-grade glioma (HGG) recurrent glioblastoma 5-ALA fluorescence pseudoprogression radionecrosis
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fonc.2022.848036/full

Παρόμοια τεκμήρια

The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
ανά: Petrović Marko, κ.ά.
Έκδοση: (2019-01-01)

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
ανά: Michael Baine, κ.ά.
Έκδοση: (2021-01-01)

The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosis
ανά: Arpita Sahu, κ.ά.
Έκδοση: (2023-04-01)

Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)
ανά: Archya Dasgupta, κ.ά.
Έκδοση: (2025-03-01)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
ανά: Ingrid Sidibe, κ.ά.
Έκδοση: (2022-01-01)

In silico study of pseudoprogression in glioblastoma: collaboration of radiologists and radiation oncologists in the estimation of extent of high dose RT region
ανά: Renata Belanova, κ.ά.
Έκδοση: (2020-09-01)

Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
ανά: Dan Liao, κ.ά.
Έκδοση: (2023-09-01)

Myeloid cells as potential targets for immunotherapy in pediatric gliomas
ανά: Stephen C. Frederico, κ.ά.
Έκδοση: (2024-03-01)

Editorial: Surgical approaches for the treatment of glioma
ανά: G. La Rocca, κ.ά.
Έκδοση: (2022-11-01)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
ανά: Laiz Laura de Godoy, κ.ά.
Έκδοση: (2023-04-01)

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
ανά: Roger Sun, κ.ά.
Έκδοση: (2017-12-01)

Histopathologically confirmed radiation-induced damage of the brain – an in-depth analysis of radiation parameters and spatio-temporal occurrence
ανά: Mario R. P. Kossmann, κ.ά.
Έκδοση: (2023-12-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
ανά: Benoît Calderon, κ.ά.
Έκδοση: (2023-07-01)

Next-Generation Sequencing Comparative Analysis of DNA Mutations between Blood-Derived Extracellular Vesicles and Matched Cancer Tissue in Patients with Grade 4 Glioblastoma
ανά: Paolo Rosa, κ.ά.
Έκδοση: (2022-10-01)

Treatment of Laryngeal Radionecrosis with Hyperbaric Oxygen Therapy: A Case Report
ανά: Ying-Che Hsu, κ.ά.
Έκδοση: (2005-02-01)

Pseudoprogression; discussion of the concept of pseudoprogression on the characteristics of tomographic changes in liver metastases of colorectal cancer patients receiving bevacizumab therapy
ανά: Pinar Ozdemir Akdur, κ.ά.
Έκδοση: (2023-09-01)

Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer
ανά: R. Riera-Sala, κ.ά.
Έκδοση: (2023-09-01)

Radionecrosis cerebral en un adulto
ανά: Duniel Abreu Casas, κ.ά.
Έκδοση: (2024-02-01)

Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps
ανά: Valeria Cuccarini, κ.ά.
Έκδοση: (2024-04-01)

MR-Guided Radiotherapy for Brain and Spine Tumors
ανά: Danilo Maziero, κ.ά.
Έκδοση: (2021-03-01)

Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature
ανά: Jacopo Lolli, κ.ά.
Έκδοση: (2023-03-01)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer
ανά: Nozomi Hayakawa, κ.ά.
Έκδοση: (2023-01-01)

Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature
ανά: Jacopo Lolli, κ.ά.
Έκδοση: (2023-09-01)

Metabolic pitfall of pseudoprogression after epcoritamab treatment
ανά: Osamu Imataki, κ.ά.
Έκδοση: (2024-12-01)

Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
ανά: Amrit S. Gonugunta, κ.ά.
Έκδοση: (2022-07-01)

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
ανά: Justin Leu, κ.ά.
Έκδοση: (2023-03-01)

Enlarged piloid astrocytoma of the midbrain: recurrence or pseudoprogression? A clinical case
ανά: Yu. Yu. Trunin, κ.ά.
Έκδοση: (2016-03-01)

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
ανά: Justin Leu, κ.ά.
Έκδοση: (2023-04-01)

Pseudoprogression in patients on immunotherapy
ανά: D. I. Yudin, κ.ά.
Έκδοση: (2019-06-01)

Pseudoprogression Disease in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy
ανά: Zhu W, κ.ά.
Έκδοση: (2023-09-01)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma
ανά: Julianna K. Bronk, κ.ά.
Έκδοση: (2018-02-01)

Advances in Pseudoprogression of Immune Checkpoint Inhibitors  in Non-small Cell Lung Cancer
ανά: Yajun TONG, κ.ά.
Έκδοση: (2024-04-01)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
ανά: Yongbo Xiang, κ.ά.
Έκδοση: (2023-07-01)

Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer
ανά: Takumi Kageyama, κ.ά.
Έκδοση: (2022-11-01)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
ανά: Justine Badloe, κ.ά.
Έκδοση: (2021-03-01)

Progress of fMRI on the recurrence and pseudoprogression in glioblastoma
ανά: FENG Quan⁃zhi, κ.ά.
Έκδοση: (2022-04-01)

Effects of Photons Irradiation on 18F-FET and 18F-DOPA Uptake by T98G Glioblastoma Cells
ανά: Francesca Pasi, κ.ά.
Έκδοση: (2020-11-01)

A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiotherapy
ανά: Ines Barrat, κ.ά.
Έκδοση: (2024-10-01)

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer
ανά: Eun Young Kim, κ.ά.
Έκδοση: (2019-04-01)

Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy
ανά: Vrankar Martina, κ.ά.
Έκδοση: (2018-10-01)